Andres Kriete

Andres Kriete serves as Teaching Professor and Associate Dean for Academic Affairs at Drexel University, leading graduate program innovation while advancing research in complex systems biology. His work bridges theoretical frameworks of self-organization and robustness with experimental aging models, notably the ERiQ (Energy Restriction in Quiescence) system for post-mitotic cells.

His educational foundation includes:

• Habilitation (Venia legendi) in Medical Informatics, University of Giessen Medical School (1997)
• PhD in Physics, University of Bremen, Germany (1985)
• Diploma in Physics, University of Bremen, Germany (1981)

Kriete's research integrates thermodynamics, control theory, and semantic information processing to decode aging mechanisms, developmental scaling, and mind-body connections. He posits aging as a robustness tradeoff where acute stress survival pathways conflict with longevity assurance, validated through computational models simulating Akt/mTOR/NF-kappaB/p53 signaling deregulation. His experimental ERiQ model replicates age-related metabolic stress in quiescent human fibroblasts.

Recent publications (2022-2025) reveal expanding focus on cognitive control in biological systems and dissipative scaling laws governing multicellular aging. His work consistently applies multiscale modeling—from molecular pathways to organismal phenotypes—with increasing integration of consciousness studies and top-down causation principles.

Administratively, Kriete chairs accreditation committees and professional development conferences while securing significant funding like the Bristol Myers Squibb Grant for the Drexel Biomed STEM Pathways Fellowship Program. He co-founded the 'Focus on Microscopy' conference series and initiated the Santa Fe Institute's Systems Biology of Aging workshop series in 2007.

His research group develops executable computational models using control theory motifs and rule-based aging descriptors, maintaining longstanding collaborations in biomedical imaging and pharmaceutical R&D training initiatives.